PCVX
Vaxcyte Inc
56.50$
+0.8%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | +78.7% | -7.2% | +497.9% | -17.4% | +210.2% | +39.9% | +149.4% | -13.3% | |
| – | +83.4% | -7.4% | +530.2% | -34.1% | +267.7% | +16.3% | +63.1% | -9.0% | |
| – | +82.9% | -10.8% | +554.8% | -82.1% | +1,109.9% | -52.4% | -2.4% | -55.2% | |
| – | +82.9% | -10.8% | +554.8% | -36.3% | +278.7% | +16.0% | +61.7% | -10.7% | |
| – | – | – | +50.0% | +300.0% | -16.7% | +260.7% | +472.8% | +125.3% | |
| – | – | – | – | – | – | – | – | – | |
| – | +14.8% | -0.6% | -3.5% | +997.6% | -11.9% | – | – | – | |
| – | +1,378.5% | +33.9% | -72.7% | -14.2% | +30.4% | +218.6% | +22.7% | +75.4% | |
| – | +57.5% | +64.6% | +324.0% | -38.7% | +41.1% | +258.6% | -3.5% | +46.8% | |
| – | +4.9% | -45.8% | – | – | +12.0% | +20.4% | -17.2% | +4.0% | |
| – | +56.5% | +19.3% | +782.3% | -77.3% | +44.9% | +48.9% | +232.2% | +46.3% | |
| – | -3.0% | -87.7% | – | – | – | – | – | – | |
| – | -286.6% | – | – | -17.9% | +235.8% | +30.1% | +166.5% | -18.8% | |
| – | – | – | – | – | – | – | – | – | |
| – | +618.0% | +90.9% | -39.5% | +75.7% | +25.0% | +49.8% | +25.6% | +11.6% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.